Artificial Intelligence Predicts Next Session’s Price Change For Take-Two Interactive Software, Verizon, Mondelez International

(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Take-Two Interactive Software TTWO, Verizon VZ and others.

Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.

Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.

Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.

In the next session, Via News will report the finding on the algorithm precision.

1. Take-Two Interactive Software (TTWO)

Shares of Take-Two Interactive Software jumped 5.94% in from $110.88 to $117.47 at 19:21 EST on Monday, after two consecutive sessions in a row of gains. NASDAQ is sliding 0.47% to $11,768.84, after five successive sessions in a row of gains.

Take-Two Interactive Software, Inc. develops, publishes, and markets interactive entertainment solutions for consumers worldwide. The company offers its products under the Rockstar Games, 2K, Private Division, and T2 Mobile Games names. It develops and publishes action/adventure products under the Grand Theft Auto, Max Payne, Midnight Club, and Red Dead Redemption names; and offers episodes and content, as well as develops brands in other genres, including the LA Noire, Bully, and Manhunt franchises. The company also publishes various entertainment properties across various platforms and a range of genres, such as shooter, action, role-playing, strategy, sports, and family/casual entertainment under the BioShock, Mafia, Sid Meier's Civilization, XCOM series, and Borderlands. In addition, it publishes sports simulation titles comprising NBA 2K series, a basketball video game; the WWE 2K professional wrestling series; and PGA TOUR 2K. Further, the company offers Kerbal Space Program, OlliOlli World, and The Outer Worlds and Ancestors: the Humankind Odyssey under Private Division; and free-to-play mobile games, such as Dragon City, Monster Legends, Two Dots, and Top Eleven. Its products are designed for console gaming systems, including PlayStation 4 and PlayStation 5; Xbox One; the Nintendo's Switch; personal computers; and mobile comprising smartphones and tablets. The company provides its products through physical retail, digital download, online platforms, and cloud streaming services. Take-Two Interactive Software, Inc. was incorporated in 1993 and is based in New York, New York.

More news about Take-Two Interactive Software.

2. Verizon (VZ)

Shares of Verizon slid 1.84% in from $38.8 to $38.09 at 19:21 EST on Monday, after five consecutive sessions in a row of gains. NYSE is jumping 0.92% to $14,894.85, following the last session’s upward trend.

Verizon Communications Inc., through its subsidiaries, provides communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business). The Consumer segment provides wireless services across the wireless networks in the United States under the Verizon and TracFone brands and through wholesale and other arrangements; and fixed wireless access (FWA) broadband through its wireless networks. It also offers wireline services in the Mid-Atlantic and Northeastern United States, as well as Washington D.C. through its fiber-optic network, Verizon Fios product portfolio, and a copper-based network. The Business segment provides wireless and wireline communications services and products, including data, video, conferencing, corporate networking, security and managed network, local and long-distance voice, network access, and various IoT services and products, as well as FWA broadband through its wireless networks. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was incorporated in 1983 and is headquartered in New York, New York.

Yearly Top and Bottom Value

Verizon’s stock is valued at $38.09 at 19:21 EST, way under its 52-week high of $55.51 and way above its 52-week low of $34.55.

Sales Growth

Verizon’s sales growth is 1.1% for the current quarter and 1.1% for the next.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 11.9% and a negative 9.9%, respectively.

Volatility

Verizon’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.46%, a negative 0.11%, and a positive 0.97%.

Verizon’s highest amplitude of average volatility was 0.46% (last week), 0.76% (last month), and 0.97% (last quarter).

More news about Verizon.

3. Mondelez International (MDLZ)

Shares of Mondelez International jumped 5.35% in from $65.66 to $69.17 at 19:21 EST on Monday, following the last session’s upward trend. NASDAQ is sliding 0.47% to $11,768.84, after five consecutive sessions in a row of gains.

Mondelez International, Inc., through its subsidiaries, manufactures, markets, and sells snack food and beverage products in the Latin America, North America, Asia, the Middle East, Africa, and Europe. It provides biscuits and baked snacks, including cookies, crackers, salted snacks, snack bars, and cakes and pastries; chocolates; and gums and candies, as well as various cheese and grocery, and powdered beverage products. The company's brand portfolio includes Oreo, Ritz, LU, CLIF Bar, and Tate's Bake Shop biscuits and baked snacks, as well as Cadbury Dairy Milk, Milka, and Toblerone chocolate. It serves supermarket chains, wholesalers, supercenters, club stores, mass merchandisers, distributors, convenience stores, gasoline stations, drug stores, value stores, and other retail food outlets through direct store delivery, company-owned and satellite warehouses, third party distributors, and other facilities, as well as through independent sales offices and agents. The company was formerly known as Kraft Foods Inc. and changed its name to Mondelez International, Inc. in October 2012. Mondelez International, Inc. was incorporated in 2000 and is headquartered in Chicago, Illinois.

More news about Mondelez International.

4. AbbVie (ABBV)

Shares of AbbVie rose 2.25% in from $154.11 to $157.58 at 19:21 EST on Monday, after two consecutive sessions in a row of gains. NYSE is jumping 0.92% to $14,894.85, following the last session’s upward trend.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

More news about AbbVie.

5. Novartis AG (NVS)

Shares of Novartis AG rose 5.46% in from $85.57 to $90.24 at 19:21 EST on Monday, after four consecutive sessions in a row of gains. NYSE is rising 0.92% to $14,894.85, following the last session’s upward trend.

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 4.8% and 2.6%, respectively.

Yearly Top and Bottom Value

Novartis AG’s stock is valued at $90.24 at 19:21 EST, under its 52-week high of $94.26 and way higher than its 52-week low of $74.09.

More news about Novartis AG.

6. Procter & Gamble (PG)

Shares of Procter & Gamble rose 4.95% in from $139.18 to $146.07 at 19:21 EST on Monday, after two successive sessions in a row of gains. NYSE is jumping 0.92% to $14,894.85, following the last session’s upward trend.

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Yearly Top and Bottom Value

Procter & Gamble’s stock is valued at $146.07 at 19:21 EST, way under its 52-week high of $164.90 and way higher than its 52-week low of $122.18.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Procter & Gamble’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 0.9%, now sitting on 80.28B for the twelve trailing months.

Moving Average

Procter & Gamble’s worth is above its 50-day moving average of $141.30 and higher than its 200-day moving average of $141.41.

More news about Procter & Gamble.

7. GlaxoSmithKline (GSK)

Shares of GlaxoSmithKline jumped 0.57% in from $34.84 to $35.04 at 19:21 EST on Monday, following the last session’s downward trend. NYSE is jumping 0.92% to $14,894.85, following the last session’s upward trend.

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Wave Life Sciences Ltd.; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Sales Growth

GlaxoSmithKline’s sales growth is negative 37.5% for the current quarter and negative 2.7% for the next.

More news about GlaxoSmithKline.

8. Electronic Arts (EA)

Shares of Electronic Arts jumped 7.38% in from $110.77 to $118.95 at 19:21 EST on Monday, after two successive sessions in a row of gains. NASDAQ is sliding 0.47% to $11,768.84, after five sequential sessions in a row of gains.

Electronic Arts Inc. develops, markets, publishes, and distributes games, content, and services for game consoles, PCs, mobile phones, and tablets worldwide. It develops and publishes games and services across various genres, such as sports, racing, first-person shooter, action, role-playing, and simulation primarily under the Battlefield, The Sims, Apex Legends, Need for Speed, and license games from others, including FIFA, Madden NFL, UFC, and Star Wars brands. The company licenses its games to third parties to distribute and host its games. It markets and sells its games and services through digital distribution and retail channels, as well as directly to mass market retailers, specialty stores, and distribution arrangements. Electronic Arts Inc. was incorporated in 1982 and is headquartered in Redwood City, California.

Sales Growth

Electronic Arts’s sales growth is negative 1% for the ongoing quarter and 20.9% for the next.

Volatility

Electronic Arts’s last week, last month’s, and last quarter’s current intraday variation average was 1.42%, 0.37%, and 1.04%.

Electronic Arts’s highest amplitude of average volatility was 1.77% (last week), 1.11% (last month), and 1.04% (last quarter).

Yearly Top and Bottom Value

Electronic Arts’s stock is valued at $118.95 at 19:21 EST, way under its 52-week high of $142.79 and above its 52-week low of $108.53.

More news about Electronic Arts.

9. Match Group (MTCH)

Shares of Match Group dropped 4.21% in from $42.2 to $40.42 at 19:21 EST on Monday, after three successive sessions in a row of gains. NASDAQ is sliding 0.47% to $11,768.84, after five consecutive sessions in a row of gains.

Match Group, Inc. provides dating products worldwide. The company's portfolio of brands includes Tinder, Match, Meetic, OkCupid, Hinge, Pairs, PlentyOfFish, and OurTime, as well as a various other brands. The company was incorporated in 1986 and is based in Dallas, Texas.

Sales Growth

Match Group’s sales growth is negative 0.5% for the current quarter and 4% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 31.7% and positive 554.5% for the next.

Moving Average

Match Group’s value is below its 50-day moving average of $44.14 and way under its 200-day moving average of $52.82.

Volatility

Match Group’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.31%, a negative 0.27%, and a positive 2.13%.

Match Group’s highest amplitude of average volatility was 1.38% (last week), 1.55% (last month), and 2.13% (last quarter).

More news about Match Group.

10. Atrion (ATRI)

Shares of Atrion dropped 7.53% in from $686.7 to $634.99 at 19:21 EST on Monday, after five successive sessions in a row of gains. NASDAQ is dropping 0.47% to $11,768.84, after five consecutive sessions in a row of gains.

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Atrion’s stock is considered to be oversold (<=20).

Volatility

Atrion’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.13%, a negative 0.21%, and a positive 2.18%.

Atrion’s highest amplitude of average volatility was 1.13% (last week), 2.75% (last month), and 2.18% (last quarter).

More news about Atrion.

11. Hasbro (HAS)

Shares of Hasbro dropped by a staggering 11.86% in from $56.83 to $50.09 at 19:21 EST on Monday, following the last session’s upward trend. NASDAQ is dropping 0.47% to $11,768.84, after five consecutive sessions in a row of gains.

Hasbro, Inc., together with its subsidiaries, operates as a play and entertainment company. Its Consumer Products segment engages in the sourcing, marketing, and sale of toy and game products. This segment also promotes its brands through the out-licensing of trademarks, characters, and other brand and intellectual property rights to third parties through the sale of branded consumer products, such as toys and apparels. Its toys and games include action figures, arts and crafts and creative play products, fashion and other dolls, play sets, preschool toys, plush products, sports action blasters and accessories, vehicles and toy-related specialty products, games, and other consumer products; and licensed products, such as apparels, publishing products, home goods and electronics, and toy products. The company's Wizards of the Coast and Digital Gaming segment engages in the promotion of its brands through the development of trading card, role-playing, and digital game experiences based on Hasbro and Wizards of the Coast games. Its Entertainment segment engages in the development, acquisition, production, distribution, and sale of world-class entertainment content, including film, scripted and unscripted television, family programming, digital content, and live entertainment. The company sells its products to retailers, distributors, wholesalers, discount stores, drug stores, mail order houses, catalog stores, department stores, and other traditional retailers, as well as ecommerce retailers; and directly to customer through Hasbro PULSE e-commerce website. Hasbro, Inc. was founded in 1923 and is headquartered in Pawtucket, Rhode Island.

Moving Average

Hasbro’s worth is way below its 50-day moving average of $59.62 and way under its 200-day moving average of $69.98.

Revenue Growth

Year-on-year quarterly revenue growth declined by 14.9%, now sitting on 6.19B for the twelve trailing months.

Volatility

Hasbro’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.84%, a negative 0.71%, and a positive 1.89%.

Hasbro’s highest amplitude of average volatility was 1.14% (last week), 1.77% (last month), and 1.89% (last quarter).

More news about Hasbro.

12. Franco (FNV)

Shares of Franco rose by a staggering 14.17% in from $126.05 to $143.91 at 19:21 EST on Monday, after five consecutive sessions in a row of gains. NYSE is rising 0.92% to $14,894.85, following the last session’s upward trend.

Franco-Nevada Corporation operates as a gold-focused royalty and streaming company in Latin America, the United States, Canada, and internationally. It operates in two segments, Mining and Energy. The company manages its portfolio with a focus on precious metals, such as gold, silver, and platinum group metals; and energy comprising oil, gas, and natural gas liquids. The company was founded in 1983 and is headquartered in Toronto, Canada.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Franco’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 3.5% and positive 3.2% for the next.

Moving Average

Franco’s value is higher than its 50-day moving average of $138.57 and above its 200-day moving average of $132.57.

More news about Franco.

13. Amerco (UHAL)

Shares of Amerco fell by a staggering 17.44% in from $66.96 to $55.28 at 19:21 EST on Monday, after three successive sessions in a row of losses. NASDAQ is falling 0.47% to $11,768.84, after five sequential sessions in a row of gains.

U-Haul Holding Company operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada. The company's Moving and Storage segment rents trucks, trailers, portable moving and storage units, specialty rental items, and self-storage spaces primarily to the household movers; and sells moving supplies, towing accessories, and propane. It also provides uhaul.com, an online marketplace that connects consumers to independent Moving Help service providers and independent self-storage affiliates; auto transport and tow dolly options to transport vehicles; and specialty boxes for dishes, computers, flat screen television, and sensitive electronic equipment, as well as tapes, security locks, and packing supplies. This segment rents its products and services through a network of approximately 2,100 company operated retail moving stores and 21,100 independent U-Haul dealers. As of March 31, 2022, it had a rental fleet of approximately 186,000 trucks, 128,000 trailers, and 46,000 towing devices; and 1,844 self-storage locations with approximately 876,000 rentable storage units. The company's Property and Casualty Insurance segment offers loss adjusting and claims handling services. It also provides moving and storage protection packages, such as Safemove and Safetow packages, which offer moving and towing customers with a damage waiver, cargo protection, and medical and life insurance coverage; Safestor that protects storage customers from loss on their goods in storage; Safestor Mobile, which protects customers stored belongings; and Safemove Plus, which provides rental customers with a layer of primary liability protection. The company's Life Insurance segment provides life and health insurance products primarily to the senior market through the direct writing and reinsuring of life insurance, medicare supplement, and annuity policies. The company was formerly known as AMERCO. U-Haul Holding Company was founded in 1945 and is based in Reno, Nevada.

Moving Average

Amerco’s value is way under its 50-day moving average of $63.67 and below its 200-day moving average of $56.73.

Yearly Top and Bottom Value

Amerco’s stock is valued at $55.28 at 19:21 EST, way under its 52-week high of $70.57 and way higher than its 52-week low of $44.79.

Volatility

Amerco’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.28%, a negative 1.02%, and a positive 1.79%.

Amerco’s highest amplitude of average volatility was 1.29% (last week), 2.06% (last month), and 1.79% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Amerco’s stock is considered to be overbought (>=80).

More news about Amerco.

14. Eli Lilly and Company (LLY)

Shares of Eli Lilly and Company jumped 5.77% in from $317.34 to $335.65 at 19:21 EST on Monday, after four successive sessions in a row of gains. NYSE is rising 0.92% to $14,894.85, following the last session’s upward trend.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Moving Average

Eli Lilly and Company’s value is higher than its 50-day moving average of $334.10 and above its 200-day moving average of $333.67.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Eli Lilly and Company’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 33.2% and positive 49.6% for the next.

More news about Eli Lilly and Company.

15. Ecopetrol S.A. (EC)

Shares of Ecopetrol S.A. dropped by a staggering 11.68% in from $11.35 to $10.02 at 19:21 EST on Monday, after five successive sessions in a row of losses. NYSE is rising 0.92% to $14,894.85, following the last session’s upward trend.

Ecopetrol S.A. operates as an integrated energy company. The company operates through four segments: Exploration and Production; Transport and Logistics; Refining, Petrochemical and Biofuels; and Electric Power Transmission and Toll Roads Concessions. It engages in the exploration and production of oil and gas; transportation of crude oil, motor fuels, fuel oil, and other refined products, including diesel, jet, and biofuels; processing and refining crude oil; distribution of natural gas and LPG; sale of refined and petrochemical products; supplying of electric power transmission services; design, development, construction, operation, and maintenance of road and energy infrastructure projects; and supplying of information technology and telecommunications services. As of December 31, 2021, the company had approximately 9,127 kilometers of crude oil and multi-purpose pipelines. It also produces and commercializes polypropylene resins and compounds, and masterbatches; and offers industrial service sales to customers and specialized management services. It has operations in Colombia, the United States, Asia, Central America and the Caribbean, Europe, South America, and internationally. The company was formerly known as Empresa Colombiana de Petróleos and changed its name to Ecopetrol S.A. in June 2003. Ecopetrol S.A. was incorporated in 1948 and is based in Bogotá, Colombia.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 130.6% and 81.3%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ecopetrol S.A.’s stock is considered to be overbought (>=80).

Moving Average

Ecopetrol S.A.’s value is below its 50-day moving average of $10.94 and below its 200-day moving average of $10.53.

Sales Growth

Ecopetrol S.A.’s sales growth is 59.4% for the current quarter and 26.6% for the next.

More news about Ecopetrol S.A..

16. Ringcentral (RNG)

Shares of Ringcentral dropped by a staggering 23.18% in from $35.82 to $27.52 at 19:21 EST on Monday, after five successive sessions in a row of losses. NYSE is jumping 0.92% to $14,894.85, following the last session’s upward trend.

RingCentral, Inc. provides software-as-a-service solutions that enable businesses to communicate, collaborate, and connect in North America. The company offers business cloud communications and contact center solutions based on its Message Video Phone? platform. Its products include RingCentral Office that provides communication and collaboration across various modes, including high-definition voice, video, SMS, messaging and collaboration, conferencing, online meetings, and fax; RingCentral Contact Center, a collaborative contact center solution that delivers omni-channel; and RingCentral Engage Digital, a digital customer engagement platform that allows enterprises to interact with their customers. The company's products also comprise RingCentral Engage Voice, a cloud-based outbound/blended customer engagement platform for midsize and enterprise companies; RingCentral Video, a video meeting service which includes our RCV video and team messaging capabilities and offers video and audio conferencing, file sharing, contact, task, and calendar management. In addition, it offers RingCentral Professional, a cloud based virtual telephone service that provides inbound call answering and management services for professionals; and RingCentral Fax that provides online fax capabilities. The company serves a range of industries, including financial services, education, healthcare, legal services, real estate, retail, technology, insurance, construction, hospitality, and state and local government, as well as others. It sells its products through a network of direct sales representatives, as well as sales agents, resellers, and channel partners. RingCentral, Inc. has strategic partnerships with Alcatel-Lucent Enterprise; and Vodafone Business. The company was incorporated in 1999 and is headquartered in Belmont, California.

Moving Average

Ringcentral’s value is way under its 50-day moving average of $36.56 and way below its 200-day moving average of $41.35.

More news about Ringcentral.

17. Biogen (BIIB)

Shares of Biogen dropped 0.25% in from $270.38 to $269.70 at 19:21 EST on Monday, after two consecutive sessions in a row of gains. NASDAQ is dropping 0.47% to $11,768.84, after five consecutive sessions in a row of gains.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB135, BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, Lecanemab, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and BIIB131 to treat acute neurology; BIIB074 for neuropathic pain; and BYOOVIZ, BIIB800, and SB15 biosimilars, which are under various stages of development. The company has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Yearly Top and Bottom Value

Biogen’s stock is valued at $269.70 at 19:21 EST, way under its 52-week high of $311.88 and way higher than its 52-week low of $187.16.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 3.5% and 13.8%, respectively.

More news about Biogen.

18. HCA Holdings (HCA)

Shares of HCA Holdings rose 2.69% in from $248 to $254.67 at 19:21 EST on Monday, following the last session’s upward trend. NYSE is jumping 0.92% to $14,894.85, following the last session’s upward trend.

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.9%, now sitting on 60.23B for the twelve trailing months.

Yearly Top and Bottom Value

HCA Holdings’s stock is valued at $254.67 at 19:21 EST, below its 52-week high of $279.02 and way above its 52-week low of $164.47.

More news about HCA Holdings.

19. Boston Beer Company (SAM)

Shares of Boston Beer Company jumped 0.31% in from $327.24 to $328.25 at 19:21 EST on Monday, after five sequential sessions in a row of gains. NYSE is rising 0.92% to $14,894.85, following the last session’s upward trend.

The Boston Beer Company, Inc. produces and sells alcohol beverages primarily in the United States. The company's flagship beer is Samuel Adams Boston Lager. It offers various beers, hard ciders, and hard seltzers under the Samuel Adams, Twisted Tea, Truly Hard Seltzer, Angry Orchard, Dogfish Head, Angel City, Coney Island, Concrete Beach brand names. The company markets and sells its products to a network of approximately 400 wholesalers in the United States, as well as international wholesalers, importers, or other agencies that in turn sell to retailers, such as grocery stores, club stores, convenience stores, liquor stores, bars, restaurants, stadiums, and other retail outlets. It also sells in products in Canada, Europe, Israel, Australia, New Zealand, the Caribbean, the Pacific Rim, Mexico, and Central and South America. The Boston Beer Company, Inc. was founded in 1984 and is based in Boston, Massachusetts.

More news about Boston Beer Company.